Ligament Alteration in Diabetes Mellitus
Olga Adamska1, Artur Stolarczyk1, Agata Gondek2
1Orthopaedic and Rehabilitation Department, Medical University of Warsaw, 02-091 Warsaw, Poland.
Journal of Clinical Medicine
|October 14, 2022
Summary
Advanced glycation end products (AGEs) accelerate connective tissue aging, particularly in diabetes mellitus (DM). This review explores AGEs
Area of Science:
- Connective tissue biology
- Metabolic disorders
- Biochemistry of aging
Background:
- Connective tissue aging is accelerated by advanced glycation end products (AGEs).
- Diabetes mellitus (DM) progression is characterized by AGEs accumulation, affecting long-lived proteins like fibrillar collagens.
- Glycation impacts tissue homeostasis, leading to reduced healing, flexibility, and quality in ligaments, tendons, bones, and skin.
Purpose of the Study:
- To review and summarize existing literature on ligament alterations in diabetes mellitus.
- To identify specific molecules involved in the degenerative processes of connective tissue in DM.
- To highlight the impact of DM on connective tissue quality of life.
Main Methods:
- Literature review and synthesis of experimental findings.
- Analysis of molecular mechanisms underlying AGEs formation and collagen cross-linking.
- Examination of morphological and functional changes in connective tissues.
Main Results:
- AGEs accumulation is a key factor in connective tissue aging and DM-related complications.
- Fibrillar collagens are particularly susceptible to glycation, altering tissue structure and function.
- Ligament alterations in DM, though impacting quality of life, are under-researched.
Conclusions:
- AGEs significantly contribute to connective tissue degeneration in aging and diabetes.
- Further research, including large-cohort studies, is needed to fully understand ligament involvement in DM complications.
- Targeting AGEs formation or cross-linking may offer therapeutic strategies for connective tissue disorders.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
2.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Pathophysiology of Diabetes
1.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes: Symptoms, Diagnosis, and Complications
657
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
657
Diabetes Mellitus: Overview and Type I Subtype
2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Dipeptidyl Peptidase 4 Inhibitors
234
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
234
Carbohydrate Metabolism
11.5K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.5K


